Medicare Enrolled
Dr. Joseph Lebowicz, MD
Hematology & Oncology · Brooklyn, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Lebowicz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lebowicz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lebowicz
Dr. Joseph Lebowicz is a hematology & oncology specialist in Brooklyn, NY, with 20 years of NPI registration. Based on federal Medicare data, Dr. Lebowicz performed 31,147 Medicare services across 2,857 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lebowicz received a total of $3,969 from 55 pharmaceutical and/or device companies across 203 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lebowicz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 16% volume in NY
$3,969 industry payments
Medicare Practice Summary
Medicare Utilization ↗31,147
Medicare services
Top 16% in NY for hematology & oncology
2,857
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,557 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
17,250 | $1 | $3 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
5,680 | $6 | $20 |
| Denosumab injection (Prolia/Xgeva) | 1,980 | $18 | $58 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,133 | $8 | $24 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,036 | $7 | $15 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
870 | $0 | $0 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
492 | $109 | $368 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
370 | $12 | $41 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
339 | $10 | $26 |
| Iron level test | 251 | $6 | $16 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
246 | $13 | $33 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
244 | $9 | $21 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
236 | $5 | $11 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
103 | $75 | $261 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
97 | $9 | $21 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
96 | $28 | $85 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
93 | $157 | $514 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
82 | $3 | $10 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
64 | $146 | $482 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
63 | $17 | $68 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
63 | $1 | $5 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
56 | $58 | $192 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
52 | $15 | $46 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
50 | $122 | $393 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
47 | $72 | $175 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
45 | $36 | $150 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
37 | $1 | $3 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
25 | $85 | $328 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
18 | $170 | $461 |
| Bone marrow smear interpretation A laboratory review of a bone marrow sample slide to examine cell structure and identify abnormalities. |
18 | $64 | $192 |
| New patient office visit, complex (60-74 min) | 11 | $207 | $636 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
56.0% high complexity
29.4% medium
14.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,969
Total received (2018-2024)
Avg $567/year across 7 years
Top 38% in NY for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
55
Companies
203
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,895 (98.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$73 (1.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$409
2023
$135
2022
$392
2021
$741
2020
$717
2019
$788
2018
$787
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$81
GlaxoSmithKline, LLC.
$50
PUMA BIOTECHNOLOGY, INC.
$45
Incyte Corporation
$45
Merck Sharp & Dohme LLC
$44
AstraZeneca Pharmaceuticals LP
$28
Mirati Therapeutics, Inc.
$26
JAZZ PHARMACEUTICALS INC.
$25
Coherus Biosciences Inc.
$24
Lilly USA, LLC
$22
ABBVIE INC.
$19
Top 3 companies account for 43.0% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$431
Amgen Inc.
$380
Takeda Pharmaceuticals U.S.A., Inc.
$186
Janssen Biotech, Inc.
$165
Celgene Corporation
$160
PFIZER INC.
$159
Astellas Pharma US Inc
$152
Octapharma USA, Inc.
$129
AstraZeneca Pharmaceuticals LP
$113
GENZYME CORPORATION
$112
TESARO, Inc.
$107
Seagen Inc.
$107
Daiichi Sankyo Inc.
$102
Incyte Corporation
$98
Merck Sharp & Dohme Corporation
$96
Bayer HealthCare Pharmaceuticals Inc.
$95
Gilead Sciences, Inc.
$91
Pharmacyclics LLC, An AbbVie Company
$76
GlaxoSmithKline, LLC.
$76
G1 Therapeutics, Inc.
$60
Karyopharm Therapeutics Inc.
$56
Regeneron Healthcare Solutions, Inc.
$52
Puma Biotechnology, Inc.
$51
Exelixis Inc.
$51
Mirati Therapeutics, Inc.
$50
Lilly USA, LLC
$47
PUMA BIOTECHNOLOGY, INC.
$45
Merck Sharp & Dohme LLC
$44
Dova Pharmaceuticals
$44
Clovis Oncology, Inc.
$44
TerSera Therapeutics LLC
$43
Ipsen Biopharmaceuticals, Inc
$41
Coherus Biosciences Inc.
$38
Taiho Oncology, Inc.
$33
Boehringer Ingelheim Pharmaceuticals, Inc.
$30
JAZZ PHARMACEUTICALS INC.
$25
EISAI INC.
$25
Jazz Pharmaceuticals Inc.
$25
AbbVie, Inc.
$23
Pharmacosmos Therapeutics Inc.
$23
Shield Therapeutics Inc
$22
EMD Serono, Inc.
$22
AMAG Pharmaceuticals, Inc.
$21
MorphoSys, US Inc.
$21
Acceleron Pharma, Inc.
$21
ARRAY BIOPHARMA INC
$21
AbbVie Inc.
$20
Cumberland Pharmaceuticals, Inc.
$20
ABBVIE INC.
$19
Sun Pharmaceutical Industries Inc.
$18
Heron Therapeutics, Inc.
$18
Eisai Inc.
$17
Seattle Genetics, Inc.
$16
Spectrum Pharmaceuticals Inc.
$15
Dendreon Pharmaceuticals LLC
$13
Top 3 companies account for 25.1% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADCETRIS · BLENREP · BOSULIF · BRAFTOVI · BYNFEZIA PEN · Bavencio · CALQUENCE · COSELA · Cabometyx · DARZALEX · Doptelet · ELELYSO · ENHERTU · EPKINLY · ERLEADA · EVENITY · FASENRA · FERAHEME · Folotyn · GILOTRIF · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LONSURF · Lenvima · Lonsurf · MONJUVI · Monoferric · NINLARO · NUWIQ · Nerlynx · Nplate · OJJAARA · ONUREG · OPDIVO · Onivyde · PROVENGE · Prolia · REBLOZYL · Reblozyl · Revlimid · Rubraca · SANCUSO · SARCLISA · SOMATULINE DEPOT · SUSTOL · SUTENT · Stivarga · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Trodelvy · Udenyca · VENCLEXTA · VERZENIO · Venclexta · Vitrakvi · XALKORI · XGEVA · XPOVIO · XTANDI · Xermelo · Xtandi · ZEJULA · ZEPZELCA · ZOLADEX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
707
Per 100K population
26.7
County median income
$78,548
Nearest hospital
NEW YORK COMMUNITY HOSPITAL OF BROOKLYN, INC.
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Lebowicz is a mixed practice specialist, with above-average Medicare volume (top 16% in NY), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Lebowicz experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Lebowicz performed 17,250 iron infusion (injectafer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lebowicz receive payments from pharmaceutical companies?
Yes. Dr. Lebowicz received a total of $3,969 from 55 companies across 203 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lebowicz's costs compare to other hematology & oncology specialists in Brooklyn?
Dr. Lebowicz's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lebowicz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Brooklyn
Browse hematology & oncology specialists in Brooklyn ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NY
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NY
Which NY hematology & oncology specialists receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology